What is Wave Life Sciences's restricted cash?

Wave Life Sciences (WVE) reported restricted cash of $3.82M in Q1 2026.

How has Wave Life Sciences's restricted cash changed year-over-year?

Wave Life Sciences's restricted cash increased by 1.1% year-over-year, from $3.77M to $3.82M.

What is the long-term trend for Wave Life Sciences's restricted cash?

Over 5 years (2020 to 2025), Wave Life Sciences's restricted cash has grown at a 0.8% compound annual growth rate (CAGR), from $3.65M to $3.81M.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Wave Life Sciences WVE Restricted Cash

Restricted Cash at other companies

Madrigal Pharmaceuticals, Inc.MDGL

$5.16M+3.1%

ALN

Alnylam PharmaceuticalsALNY

$1.64M-36.8%

Beam TherapeuticsBEAM

$6.69M+1.3%

MeiraGTx Holdings plcMGTX

$2.22M+6.2%

ImmunomeIMNM

$210K+110%

Relay Therapeutics, Inc.RLAY

$1.34M-37.0%

Segments

By geography

See full

Cambridge MA$1M—

Other financials

Income statement

See full

Revenue$38.2M+317%

Operating income-$31.3M+37.2%

Net income-$26.1M+44.4%

EPS (diluted)-$0.13+55.2%

Balance sheet

See full

Cash & equivalents$544.6M+124%

Total debt$15.7M-33.4%

Total equity$511.7M+198%

Total assets$583.5M+102%

Cash flow

See full

Operating cash flow-$59.6M+5.5%

CapEx$438.0K+165%

Free cash flow-$60.0M+5.1%

Valuation

See full

Market cap$1.14B+13.0%

Enterprise value$615.92M-22.3%

P/S15.1×-12.2×

Profitability

See full

Operating margin-75.7%-33.6pp

Net margin-66.5%-29.9pp

FCF margin-27.2%-12.6pp

Returns & leverage

See full

Return on equity-53.7%—

Debt / equity0×-0.1×

Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsNoncurrent.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's restricted cash?: Wave Life Sciences (WVE) reported restricted cash of $3.82M in Q1 2026.
How has Wave Life Sciences's restricted cash changed year-over-year?: Wave Life Sciences's restricted cash increased by 1.1% year-over-year, from $3.77M to $3.82M.
What is the long-term trend for Wave Life Sciences's restricted cash?: Over 5 years (2020 to 2025), Wave Life Sciences's restricted cash has grown at a 0.8% compound annual growth rate (CAGR), from $3.65M to $3.81M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.